This treatment is commonly used to support energy levels, improve metabolism, and enhance overall vitality
Research in diabetic models indicates that ARA-290 may improve metabolic homeostasis
In the SURMOUNT-1 study, a phase 3 clinical trial in obese patients, randomized participants in a 1:1:1:1 ratio to tirzepatide (5, 10, 15 mg) or placebo over 72 weeks, significant weight reductions were observed at 72 weeks: 15.0% for 5 mg, 19.5% for 10 mg, 20.9% for 15 mg, compared to 3.1% for placebo [18]
Critically, autophagy is characterized by high specialization, such as mitophagy, reticulophagy and lipophagy (144)
It is safe, well-tolerated, and scientifically supported for promoting fat metabolism, endurance, and recovery